Related Experiment Video

Updated: May 30, 2026

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092
08:53

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

The immunogenicity of pneumococcal polysaccharides in infants and children: a meta-regression

Craig Laferriere1

  • 1CANVAX, 3561 Gallager Dr., Mississauga, Ontario, L5C 2N2, Canada. craiglaferriere@gmail.com

Vaccine
|August 6, 2011
PubMed

Insights

Pneumococcal polysaccharide vaccines show increased immunogenicity with age in infants and children. Vaccine responses vary by country, with higher responses in lower GDP nations, and some serotypes are less immunogenic.

Area of Science:

  • Immunology
  • Pediatrics
  • Vaccinology

Background:

  • Pneumococcal polysaccharide vaccines (PPSV) are crucial for preventing pneumococcal disease.
  • Understanding the immunogenicity of plain PPSV in young children is essential for optimizing vaccination strategies.

Purpose of the Study:

  • To systematically review and analyze the immunogenicity of plain pneumococcal polysaccharides in infants and children.
  • To identify factors influencing vaccine response, including age, dosage, and geographical location.

Main Methods:

  • Systematic literature search and meta-regression analysis.
  • Evaluation of immunogenicity defined as fold-increase in serotype-specific antibody concentration post-vaccination.
  • Analysis of variables: subject age, sampling time, dosage, immunization route, vaccine composition, and study location.

Main Results:

  • Immunogenicity significantly increases with age, particularly within the first 11 months of life.
  • Higher vaccine responses were observed in countries with lower Gross Domestic Product (GDP).
  • Specific serotypes (6A, 6B, 14, 19F, 23F) demonstrated lower initial immunogenicity compared to others (2, 3, 4, 7F, 8, 9N, 9V, 18C), with responses converging by age 6.

Conclusions:

  • Age is a critical determinant of pneumococcal polysaccharide vaccine immunogenicity in young children.
  • Geographical factors, potentially related to GDP, influence vaccine efficacy.
  • Differences in serotype immunogenicity may be explained by T-independent immune response mechanisms.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...